25 Participants Needed

High-Dose Folic Acid Supplementation for Metabolic Health During Pregnancy

YL
AM
Overseen ByAmy McMahon, PhD
Age: 18 - 65
Sex: Female
Trial Phase: Academic
Sponsor: University of British Columbia
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

Yes, you will need to stop taking long-term prescription medications like hormonal contraceptives, antidepressants, anticonvulsants, anticoagulants, or other chronic medications to participate in this trial.

What data supports the effectiveness of the drug 5-methyltetrahydrofolate, calcium salt, Folic Acid for metabolic health during pregnancy?

Research shows that folic acid supplementation during pregnancy is linked to higher birth weights and lower risks of preeclampsia (a pregnancy complication characterized by high blood pressure) and gestational hypertension (high blood pressure during pregnancy). Additionally, high-dose folic acid supplements have been associated with improved recovery rates in women with gestational diabetes.12345

Is high-dose folic acid supplementation safe during pregnancy?

Research shows that folic acid and its alternative, calcium L-methylfolate, are generally safe for use in humans. Studies found no harmful effects on behavior, body weight, or organ health in animals, and folic acid is widely recommended for pregnant women to support healthy pregnancy outcomes.56789

How does the drug 5-methyltetrahydrofolate, calcium salt, differ from other treatments for metabolic health during pregnancy?

5-methyltetrahydrofolate, calcium salt, is a form of folate that is already in its active form, unlike folic acid which needs to be converted in the body. This may reduce the risk of masking vitamin B12 deficiency symptoms and potentially interacts less with certain medications, making it a unique option for improving folate status during pregnancy.1011121314

What is the purpose of this trial?

This trial compares synthetic folic acid and natural 5-MTHF to see how they affect nutrient processing in healthy people. It uses special tracking methods to observe these changes and considers genetic differences in a key enzyme. 5-MTHF is a natural form of folate that is well absorbed and more bioavailable than synthetic folic acid, even in individuals with metabolic defects.

Research Team

YL

Yvonne Lamers, PhD

Principal Investigator

University of British Columbia

Eligibility Criteria

This trial is for generally healthy individuals with a BMI of 19-24 kg/m2 and normal levels of folate, vitamin B12, and B6. It's not for those who've used certain supplements recently, have chronic diseases like diabetes or asthma, are pregnant or breastfeeding, smoke, use drugs, drink heavily, can't swallow pills or consent in English.

Inclusion Criteria

Body mass index of between 19-24 kg/m2
Normal folate, vitamin B12, and B6 status
Generally healthy

Exclusion Criteria

Blood donation in the last three months prior to study start
Use of vitamin supplements, amino acid or protein supplements for more than six months before study participation
Chronic consumption of a high-protein diet (e.g. Atkins Diet)
See 8 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either folic acid or 5-MTHF supplementation. Folic acid: 1 mg daily for 12 weeks, then 5 mg daily for 12 weeks. 5-MTHF: 1 mg daily for 12 weeks, then 5 mg daily for 12 weeks.

24 weeks
3 visits (in-person) at baseline, Week 12, and Week 24

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • 5-methyltetrahydrofolate, calcium salt
  • Folic Acid
Trial Overview The study compares the effects of high-dose folic acid versus a natural form called 5-MTHF on DNA-related cellular mechanisms in humans. Researchers will track how these substances influence metabolic pathways using stable isotope tracer protocols.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Folic acid supplementationExperimental Treatment1 Intervention
Folic acid will be given orally in form of tablets. A supplement of 1 mg will be taken daily for 12 weeks. Thereafter, a supplement of 5 mg will be taken daily for 12 weeks (i.e., until Week 24). At baseline, Week 12, and Week 24, subjects will receive a 9-hour primed constant infusion of amino acids in saline solution for quantification of kinetics of one-carbon metabolism.
Group II: 5-MTHF supplementationExperimental Treatment1 Intervention
The calcium salt of 5-methyltetrahydrofolate (5-MTHF; Brand name "Metafolin") will be given orally in form of tablets. A supplement of 1 mg will be taken daily for 12 weeks. Thereafter, a supplement of 5 mg will be taken daily for 12 weeks (i.e., until Week 24). At baseline, Week 12, and Week 24, subjects will receive a 9-hour primed constant infusion of amino acids in saline solution for quantification of kinetics of one-carbon metabolism.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of British Columbia

Lead Sponsor

Trials
1,506
Recruited
2,528,000+

References

Maternal folate, one-carbon metabolism and pregnancy outcomes. [2023]
Folic acid supplementation in early pregnancy and the risk of preeclampsia, small for gestational age offspring and preterm delivery. [2022]
Enhanced recovery in patients with gestational diabetes mellitus and MTHFR 677 TT genotype after taking high-dose folic acid supplements during mid-late pregnancy: an open-label interventional study. [2023]
Vitamin B12 Status among Pregnant Women in the UK and Its Association with Obesity and Gestational Diabetes. [2022]
Supplementation of folic acid in pregnancy and the risk of preeclampsia and gestational hypertension: a meta-analysis. [2019]
Safety evaluation of calcium L-methylfolate. [2023]
Folic acid supplementation: what is new? Fetal, obstetric, long-term benefits and risks. [2020]
[6S]5-methyltetrahydrofolate or folic acid supplementation and absorption and initial elimination of folate in young and middle-aged adults. [2021]
5-Methyl-tetrahydrofolate in prevention of recurrent preeclampsia. [2017]
Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics. [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
Lactating Canadian Women Consuming 1000 µg Folic Acid Daily Have High Circulating Serum Folic Acid Above a Threshold Concentration of Serum Total Folate. [2023]
Enhanced oral bioavailability of a novel folate salt: comparison with folic acid and a calcium folate salt in a pharmacokinetic study in rats. [2017]
Pharmacokinetics of Sodium and Calcium Salts of (6S)-5-Methyltetrahydrofolic Acid Compared to Folic Acid and Indirect Comparison of the Two Salts. [2021]
14.United Statespubmed.ncbi.nlm.nih.gov
[6S]-5-Methyltetrahydrofolate is at least as effective as folic acid in preventing a decline in blood folate concentrations during lactation. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security